Send us Feedback

BioCryst Pharmaceuticals (BCRX)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Cash & Equivalents 28.6M 53.5M 24.3M 37.1M 28.9M
Short Term Investments 15.6M 0 17.1M 0 0
Accounts Receivable 5.85M 5.08M 3.77M 4.56M 4.33M
Inventories 263K 0 263K 0 0
Pre-paid Expenses 407K 0 826K 0 0
Deferred Tax Assets 452K 0 404K 0 0
Other Current Assets 1.74M 0 0 0 -33.2M
Total Current Assets 52.9M 58.5M 46.6M 41.6M 0
Property, Plant & Equipment 999K 0 751K 0 0
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 20.8M 17.7M 11.6M 15.8M 46.9M
Total Long-Term Assets 27.1M 17.7M 17.5M 15.8M 46.9M
Total Assets 80.1M 76.2M 64.1M 57.4M 46.9M
Accounts Payable 2.06M 0 2.29M 0 0
Accrued Expenses 0 0 0 0 0
Short Term Debt 0 0 0 0 0
Other Current Liabilities 2.40M 0 1.31M 0 0
Total Current Liabilities 16.2M 0 12.6M 0 0
Long Term Debt 30.0M 30.0M 30.0M 30.0M 30.0M
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 10.8M 30.6M 11.7M 27.9M 19.7M
Total Long-term Liabilities 40.8M 60.6M 41.7M 57.9M 49.7M
Minority Interest 0 0 0 0 0
Total Liabilities 56.9M 60.6M 54.3M 57.9M 49.7M
Preferred Stock 0 0 0 0 0
Common Par 492K 0 509K 0 0
Additional Paid-In Capital 382M 0 391M 0 0
Retained Earnings -360M -372M -382M -393M -397M
Treasury Stock 0 0 0 0 0
Other Equity 49.0K 388M 40.0K 392M 394M
Total Shareholder's Equity 23.1M 15.7M 9.78M -454K -2.84M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki